The estimated Net Worth of Jamie Dananberg is at least $746 millier dollars as of 31 March 2023. Dr Dananberg owns over 420 units of Unity Biotechnology Inc stock worth over $87,944 and over the last 7 years he sold UBX stock worth over $21,937. In addition, he makes $635,790 as Chief Medical Officer at Unity Biotechnology Inc.
Sign up
Dr D UBX stock SEC Form 4 insiders trading
Dr has made over 7 trades of the Unity Biotechnology Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 420 units of UBX stock worth $714 on 31 March 2023.
The largest trade he's ever made was selling 10,923 units of Unity Biotechnology Inc stock on 14 September 2022 worth over $5,243. On average, Dr trades about 971 units every 12 days since 2018. As of 31 March 2023 he still owns at least 62,817 units of Unity Biotechnology Inc stock.
You can see the complete history of Dr Dananberg stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Jamie Dananberg M.D. biography
Dr. Jamie Dananberg M.D. is the Chief Medical Officer at Unity Biotechnology Inc.
What is the salary of Dr D?
As the Chief Medical Officer of Unity Biotechnology Inc, the total compensation of Dr D at Unity Biotechnology Inc is $635,790. There are 4 executives at Unity Biotechnology Inc getting paid more, with Keith Leonard having the highest compensation of $3,270,820.
How old is Dr D?
Dr D is 63, he's been the Chief Medical Officer of Unity Biotechnology Inc since . There are 2 older and 19 younger executives at Unity Biotechnology Inc. The oldest executive at Unity Biotechnology Inc is David Lacey, 67, who is the Independent Director.
What's Dr D's mailing address?
Jamie's mailing address filed with the SEC is C/O UNITY BIOTECHNOLOGY, INC., 285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080.
Insiders trading at Unity Biotechnology Inc
Over the last 7 years, insiders at Unity Biotechnology Inc have traded over $9,012,473 worth of Unity Biotechnology Inc stock and bought 3,200 units worth $28,480 . The most active insiders traders include Kristina Burow, Robert Nelsen et Nathaniel E David. On average, Unity Biotechnology Inc executives and independent directors trade stock every 54 days with the average trade being worth of $65,316. The most recent stock trade was executed by Alexander Hieu Nguyen on 2 August 2024, trading 154 units of UBX stock currently worth $236.
What does Unity Biotechnology Inc do?
unity biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. unity's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. more information is available at www.unitybiotechnology.com.
What does Unity Biotechnology Inc's logo look like?
Complete history of Dr Dananberg stock trades at Unity Biotechnology Inc
Unity Biotechnology Inc executives and stock owners
Unity Biotechnology Inc executives and other stock owners filed with the SEC include:
-
Keith Leonard,
Chairman of the Board -
Margo Roberts,
Independent Director -
Nathaniel David,
President, Co-Founder, Director -
Dr. Anirvan Ghosh,
CEO & Director -
Dr. Jamie Dananberg M.D.,
Chief Medical Officer -
Dr. Jamie Dananberg,
Chief Medical Officer -
Lynne Marie Sullivan,
CFO & Head of Corp. Devel. -
Paul Berns,
Independent Director -
Graham Cooper,
Independent Director -
David Lacey,
Independent Director -
Kristina Burow,
Independent Director -
Camille Samuels,
Independent Director -
Robert Nelsen,
Director -
Dr. Nathaniel E. David A.B., Ph.D.,
Co-Founder & Exec. Director -
Luis Visoso,
Director -
Mary Campbell,
Director -
Jamie Dananberg,
Chief Medical Officer -
Tamara Tompkins,
General Counsel and Corporate Secretary -
Dan Marquess,
Chief Scientific Officer -
Lynne Sullivan,
Chief Financial Officer, Chief Accounting Officer -
Anirvan Ghosh,
Chief Executive Officer, Director -
Dr. Nathaniel E. David,
Co-Founder & Exec. Director -
Susan Lundeen Smuck,
Chief HR Officer -
Dr. Przemyslaw Sapieha Ph.D.,
Chief Scientific Advisor -
Alexander Azoy,
VP of Fin., Chief Accounting Officer, Controller & Principal Accounting Officer -
Nathan Guz Ph.D.,
VP of Operations -
Daohong Zhou M.D.,
Founder -
Dr. Judith Campisi,
Founder -
Dr. Jan M. van Deursen,
Founder -
Alexander Azoy,
See Remarks -
Alexander Hieu Nguyen,
Chief Legal Officer -
Ii Robert C. Goeltz,
Chief Financial Officer -
Venture Partners Vii, Llcar...,
-
Michael P. Samar,
-
Gilmore Neil O'neill,